Trending Now
Markets continue their upward march unabated
Markers continue their upward march unabated. Despite rising death tolls from the coronavirus, equity markets feel obliged to push to new highs....
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
A Spoonful of Sugarmade Inc (OTCMKTS:SGMD)?
Every industry goes through an evolutionary process. It’s path-dependent in many ways, and you know conceptual factors, at least analogically. Cannabis is no different....
MAKE IT MODERN
LATEST REVIEWS
Avenue Therapeutics Inc.’s (NASDAQ: ATXI) IV Tramadol Receives FDA Rejection
Avenue Therapeutics Inc. (NASDAQ: ATXI) has announced the outcome of its US FDA joint meeting of the Anaesthetic and Analgesic Drug Products Advisory Committee...
MAKE IT MODERN
PERFORMANCE TRAINING
NantKwest Inc. (NASDAQ:NK) And ImmunityBio Add Cohort 3 In Phase 2 Pancreatic Cancer Study...
NantKwest Inc. (NASDAQ:NK) has announced the addition of a third cohort to its ongoing Phase 2 study if its novel immunotherapy for the treatment...
Epizyme Inc. (NASDAQ:EPZM) Receives FDA Approval For TAZVERIK sNDA In Two Folicular Lymphoma Indications
Epizyme Inc. (NASDAQ:EPZM) has announced that its drug TAZVERIK (tazemetostat) has received FDA approval for supplemental New Drug Application for two distinct follicular lymphoma...
Omicron Minimally Impacts SARS-CoV-2 T Cell Epitopes Within Gritstone Bio Inc.’s (NASDAQ: GRTS) mRNA...
Gritstone Bio Inc. (NASDAQ: GRTS) has announced that the SARS-CoV-2 T Cell epitopes given within the company’s self-amplifying mRNA COVID vaccines experience minimal impact...
Ocugen Inc. (NASDAQ: OCGN) and Bharat Biotech Announce Study Results Showing COVAXIN Can Neutralize...
Ocugen Inc. (NASDAQ: OCGN) and its Bharat Biotech have announced results of a study carried at Emory University showing that sera from participants that...
Aslan Pharmaceuticals Ltd (NASDAQ:ASLN) Kicks Off Third Dose Cohort In Its Study Evaluating ASLAN004...
Aslan Pharmaceuticals Ltd (NASDAQ:ASLN) recently announced the shift to the third dose cohort of its developmental atopic dermatitis treatment called ASLAN004 as part of...
MAKE IT MODERN
